Biopsy Devices Market, Global Forecast, by Products (Biopsy Needles, Guidance Systems, Biopsy Guns Reagents and kits and others), Regions, Application, Companies
|出版日||ページ情報||英文 167 Pages
|生検装置の世界市場の予測 Biopsy Devices Market, Global Forecast, by Products (Biopsy Needles, Guidance Systems, Biopsy Guns Reagents and kits and others), Regions, Application, Companies|
|出版日: 2019年08月01日||ページ情報: 英文 167 Pages||
The surgically removal of a tissue from any human organ to know the presence of a disease especially cancer is called biopsy. This medical procedure is done by surgeons, cardiologist and radiologist. Global biopsy device market is anticipated to surpass USD 2.8 Billion by the year end of 2025. The main factor that fuel the market growth is minimal invasive surgical procedure which mitigate the complications and side-effects and proliferating the biopsy device. Increasing private funding for cancer research, government expenditure on healthcare across the world, rising technological up-gradation and favorable reimbursement policies will further propel the global biopsy device market in coming future.
As per world cancer report by the end of year 2020 there will be 15 Million new cancer cases. The rising prevalence of cancer disease across the world like breast cancer, lung cancer, prostate cancer etc will drive the market of biopsy devices. These days, people are more health conscious and they are shifting towards minimal invasive technique over conventional technique to ensure complete safety.
Renub Research report titled "Biopsy Devices Market, Global Forecast, by Products (Biopsy Needles, Guidance Systems, Biopsy Guns Reagents and kits and others), Regions (North America, Europe, Asia-Pacific & Rest of the World), Application (Breast Biopsy, Lung Biopsy, Prostate Biopsy and Others) Companies (C. R. Bard, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Cardinal Health, Inc., Olympus Corporation, Boston Scientific Corporation, Medtronic plc, Hologic, Inc.)" captures a detailed analysis of global Biopsy Devices market and volume and provides an all-encompassing analysis of the key growth drivers and preventive factors, key players and their projections for the future.
In this report, we have done comprehensive analysis of different types of Biopsy Device product. By biopsy device product, the market is categorized into 4 parts; Biopsy Needle, Guidance system segment, Biopsy Guns, Reagents and kits in which Biopsy needle is one of the most significant segment in global biopsy device market.
Besides, this report also discusses about the market of Guidance system, say for instance (Clinically-guided, Stereotactic-guided, Ultrasound-guided) and Reagents & kits system. The above mentioned markets of devices make a great impact on this market due to inclination on minimally invasive surgeries as well as rising prevalence of cancer's like Prostate, Breast and Lungs.
In this report, we have fragmented the global biopsy device market on the basis of application into three parts; Breast Biopsy, Lung Biopsy and Prostate Biopsy. The prevalence of breast cancer and prostate cancer across the world is rising at the rapid pace and demand of minimally invasive surgeries among the people is also rising and hence it will further propel the market growth of global biopsy device. In this report, breast biopsy alone dominated the biopsy device market.
In this report, we have done complete insight on regional analysis of global biopsy device market. We have categorized the market into four regional front; North America, Europe, Asia-Pacific and Rest of the world. Asia-Pacific will be one of the fastest growing markets for biopsy device.
The key players in this industry include: C. R. Bard, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Cardinal Health, Inc., Olympus Corporation, Boston Scientific Corporation, Medtronic plc, and Hologic, Inc. The company focuses on the development of new products, partnerships and acquisitions to maintain their positions in the market.